Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
Immunoglobulin E Antibody
100%
Immunoglobulin E
98%
Chondroitin Sulfate Proteoglycan
49%
Gamma Urogastrone
49%
Rat Model
27%
Immunocompetent Cell
26%
Melanoma Antigen
24%
Trastuzumab
24%
Programmed Death-Ligand 1
24%
Cancer Cell
20%
Immunotherapy
20%
Antineoplastic Activity
16%
Xenograft
16%
Therapeutic Antibodies
15%
Hypersensitive Response
13%
Fc Receptor
10%
Type I Hypersensitivity
9%
Cell Surface
9%
Macrophage
9%
Antibody-Dependent Cell-Mediated Cytotoxicity
8%
Avelumab
8%
Immune Response
8%
Antiparasitic Agent
8%
Hypersensitivity
8%
Glycosylation
8%
Cyclin E
8%
Tumor Antigen
6%
Cytotoxicity
5%
Basophil
5%
Tumor Cell
5%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
27%
Neoplasm
26%
Immunoglobulin E
24%
Immunoglobulin E Antibody
24%
Triple Negative Breast Cancer
24%
Cancer Model
24%
Solid Malignant Neoplasm
8%
Diseases
8%
Erethism
8%
Allergic Reaction
8%
Clinical Trial
8%
Antiparasitic Agent
8%
Immunotherapy
7%
Medicine and Dentistry
Cyclin-Dependent Kinase
24%
Triple Negative Breast Cancer
24%
Cancer Model
24%
Programmed Death-Ligand 1
24%
Cancer Cell
9%
Neoplasm
9%
Immunocompetent Cell
9%
Immunotherapy
7%